Search

everythinglearnresearchcommunity

for

Search:↓

A girl with hereditary chorea, likely Huntington's disease, had her condition worsened by lupus.

New technologies show promise in healing wounds, treating cancer, autoimmune diseases, and genetic disorders.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

The conclusions are: fecal short-chain fatty acids may help prevent cancer, fiber intake can reduce obesity, weight loss is hard for obese people, low BMI cancer patients are more prone to chemotherapy side effects, intermittent fasting benefits gut health, cherry laurel has health benefits in rats, certain gene variations can increase stress in hair loss patients, fecal acids can affect blood sugar levels, cold agglutinin can affect blood test results in autoimmune patients, and people with Crohn's disease have higher levels of a certain chemical in their blood.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Vitiligo causes white skin patches and can lead to psychological stress.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Human hair shows promise for non-invasive medical testing, but more research is needed to standardize its use.

A group has developed therapies that show promise for treating cancer and various other conditions.

A man's red tattoo caused a skin reaction and hair loss in his beard, which improved after treatment.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Taking He Shou Wu (Polygonum multiflorum) caused liver injury in a woman using it for hair loss.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

A girl with severe hair loss saw hair regrowth after using cannabis.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Alopecia areata often starts around age 23, can be permanent in 30% of cases, and treatments are usually temporary.

A woman with Budd-Chiari syndrome improved after treatment and needs a liver transplant, highlighting the importance of considering non-criteria antiphospholipid syndrome in similar cases.